The Uniirradiated in the PSA era. versity of Texas, M. D. Anderson Cancer Center, ## METHODS. The authors analyzed the outcome for a group of 938 men with T1-T4,
Molecular analysis of the prostate-specific antigen upstream gene enhancer
β Scribed by George Farmer; E. Sander Connolly Jr; J. Mocco; Leonard P. Freedman
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 254 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Although many physicians measure serum prostate specific antigen (PSA) during the follow-up of patients with hormone refractory prostate carcinoma (HRPC), little has been done to formalize the determination of how these serial values of PSA impact on prognosis. To understand HRPC fu
One hundred consecutive men with adenocarcinoma of the prostate, treated by modified pelvic lymphadenectomy and radical retropubic prostatectomy, were evaluated, comparing DNA ploidy as determined by flow cytometry to surgical tumor stage (pT), preoperative prostatic specific antigen (PSA), Gleason